These results are consistent with a previous report, which showed that Z-VAD-FMK (a caspase-1 inhibitor) could significantly decrease the secretion of IL-1β in patients with S. aureus-induced sepsis by inhibiting caspase activity [23]. The gene discussed is IL1B; the disease is Sepsis.